These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10419005)

  • 1. Intratumoral levels of estrogens in breast cancer.
    Blankenstein MA; van de Ven J; Maitimu-Smeele I; Donker GH; de Jong PC; Daroszewski J; Szymczak J; Milewicz A; Thijssen JH
    J Steroid Biochem Mol Biol; 1999; 69(1-6):293-7. PubMed ID: 10419005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
    Geisler J
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):245-53. PubMed ID: 14623518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole.
    de Jong PC; van de Ven J; Nortier HW; Maitimu-Smeele I; Donker TH; Thijssen JH; Slee PH; Blankenstein RA
    Cancer Res; 1997 Jun; 57(11):2109-11. PubMed ID: 9187104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral estrogen production in breast carcinoma: significance of aromatase.
    Suzuki T; Miki Y; Ohuchi N; Sasano H
    Breast Cancer; 2008; 15(4):270-7. PubMed ID: 18622573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens in tissues: uptake from the peripheral circulation or local production.
    Thijssen JH; Blankenstein MA; Miller WR; Milewicz A
    Steroids; 1987; 50(1-3):297-306. PubMed ID: 3504065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitor development for treatment of breast cancer.
    Masamura S; Adlercreutz H; Harvey H; Lipton A; Demers LM; Santen RJ; Santner SJ
    Breast Cancer Res Treat; 1995; 33(1):19-26. PubMed ID: 7749129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen production and action.
    Nelson LR; Bulun SE
    J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S116-24. PubMed ID: 11511861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aromatase with CGS 16949A in postmenopausal women.
    Santen RJ; Demers LM; Adlercreutz H; Harvey H; Santner S; Sanders S; Lipton A
    J Clin Endocrinol Metab; 1989 Jan; 68(1):99-106. PubMed ID: 2521224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism.
    Brueggemeier RW; Gu X; Mobley JA; Joomprabutra S; Bhat AS; Whetstone JL
    Ann N Y Acad Sci; 2001 Dec; 948():51-66. PubMed ID: 11795395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer.
    Demers LM; Lipton A; Harvey HA; Kambic KB; Grossberg H; Brady C; Santen RJ
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):687-91. PubMed ID: 8476785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid dynamics in the normal and carcinomatous mammary gland.
    Vermeulen A; Deslypere JP; Paridaens R
    J Steroid Biochem; 1986 Nov; 25(5B):799-802. PubMed ID: 3027457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the significance of in situ production of oestrogens in human breast cancer tissue.
    Blankenstein MA; Maitimu-Smeele I; Donker GH; Daroszewski J; Milewicz A; Thijssen JH
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):891-6. PubMed ID: 1314086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships of sex steroid hormone levels in benign and cancerous breast tissue and blood: A critical appraisal of current science.
    Stanczyk FZ; Mathews BW; Sherman ME
    Steroids; 2015 Jul; 99(Pt A):91-102. PubMed ID: 25554581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibitors: assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression.
    Lønning PE; Geisler J
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):196-202. PubMed ID: 17996443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.
    Lønning PE; Haynes BP; Dowsett M
    Eur J Cancer; 2014 Apr; 50(6):1055-64. PubMed ID: 24507547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.